Viz.ai Receives FDA 510(k) Clearance for Artificial Intelligence Algorithm for the Quantification of Intracerebral Hemorrhage

  Viz.ai, a pioneering force in AI-driven disease detection and intelligent care coordination, has attained a significant milestone with the receipt ...

February 12, 2024 | Monday | News
Aizon Raises $20M in Series C Funding to Revolutionize Pharma Manufacturing

      Aizon, the AI SaaS provider transforming pharmaceutical manufacturing, announced today the closing of a $20 million...

February 09, 2024 | Friday | News
Qubit Pharma, Institut Curie, and University of Bordeaux Collaborate on Innovative Cancer Therapies

The three partners are joining forces to develop drug candidates that modulate the immune response of cancer patients and block the development of metast...

January 30, 2024 | Tuesday | News
German Company FUSE-AI Launches Groundbreaking AI Algorithm for Radiology to the Market

Prostate.Carcinoma.ai“ significantly aids radiologists by automatically segmenting the prostate gland in MRI scans and independently identifying path...

January 29, 2024 | Monday | News
Seegene Teams Up with Microsoft for a Disease-Free World Vision

Strategic collaboration to open a new chapter in the field of molecular diagnostics that aspires to 'a world free from all diseases and future pandemics'...

January 24, 2024 | Wednesday | News
SyntheticGestalt, Enamine Partner for AI-Driven Drug Discovery Model

SyntheticGestalt, a research and development company specializing in the application of AI to the life sciences domain, and Enamine, the world's leading pr...

January 15, 2024 | Monday | News
Ultromics Partners to Accelerate Echo AI Algorithm for Early Cardiac Amyloidosis Detection

Under the partnership with Pfizer, Ultromics will research and pursue FDA clearance for its EchoGo® Amyloidosis algorithm that already has Breakthrough...

January 15, 2024 | Monday | News
Cleerly® Launches Cleerly® ISCHEMIA™ Solution for Heart Disease Analysis

Cleerly, the company working to create a new standard of care for the diagnosis of heart disease,  announced the launch of Cleerly ISCHEMIA, which rec...

January 10, 2024 | Wednesday | News
VantAI Renews Partnership with Blueprint Medicines for Innovative Drug Discovery

-- VantAI’s advanced geometric deep learning platform will be used to generate innovative proximity modulating therapeutics, including molecular glue...

January 10, 2024 | Wednesday | News
Deepcell and NVIDIA Collaborate to Boost Generative AI in Single Cell Research

Deepcell, which already uses the NVIDIA A4000 and NVIDIA AI technology, will incorporate NVIDIA AI into its single cell analysis technology, work...

January 09, 2024 | Tuesday | News
Wolters Kluwer leaders predict accelerated AI transformation for healthcare in 2024

As 2024 nears, the healthcare landscape is undergoing unprecedented transformations, particularly with headlines about artificial intelligence (AI) technol...

December 21, 2023 | Thursday | News
ImpriMed Secures $23M in Series A to Expand AI-Powered Cancer Treatment Technology

ImpriMed, a leading precision medicine startup focused on leveraging artificial intelligence to improve cancer treatment,  announced the close of a $2...

December 20, 2023 | Wednesday | News
Thrive Bioscience Launches Innovative Live Cell Imaging Software for Improved Cell-Based Research

Thrive Bioscience Inc., a provider of innovative automated live cell imaging instruments and software, debuted its CellAssist Software Release 5.0, a new i...

December 20, 2023 | Wednesday | News
Atomic AI Optimizes RNA Therapeutic Development with Chemical Mapping Data

Atomic AI’s ATOM-1 large language model (LLM) demonstrates state-of-the-art accuracy for predicting RNA structure and function Technology can be exp...

December 18, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close